DE69914472D1 - Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung - Google Patents

Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung

Info

Publication number
DE69914472D1
DE69914472D1 DE69914472T DE69914472T DE69914472D1 DE 69914472 D1 DE69914472 D1 DE 69914472D1 DE 69914472 T DE69914472 T DE 69914472T DE 69914472 T DE69914472 T DE 69914472T DE 69914472 D1 DE69914472 D1 DE 69914472D1
Authority
DE
Germany
Prior art keywords
levosimend
active substance
medicinal products
substance administration
controlled active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69914472T
Other languages
English (en)
Other versions
DE69914472T2 (de
Inventor
Ilkka Larma
Maarit Baeckman
Saila Antila
Lasse Lehtonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69914472(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE69914472D1 publication Critical patent/DE69914472D1/de
Publication of DE69914472T2 publication Critical patent/DE69914472T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69914472T 1998-04-23 1999-04-23 Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung Expired - Lifetime DE69914472T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI980901 1998-04-23
FI980901A FI980901A (fi) 1998-04-23 1998-04-23 Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
PCT/FI1999/000329 WO1999055305A2 (en) 1998-04-23 1999-04-23 Controlled release peroral compositions of levosimendan

Publications (2)

Publication Number Publication Date
DE69914472D1 true DE69914472D1 (de) 2004-03-04
DE69914472T2 DE69914472T2 (de) 2004-11-11

Family

ID=8551575

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69914472T Expired - Lifetime DE69914472T2 (de) 1998-04-23 1999-04-23 Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung

Country Status (38)

Country Link
US (1) US7045147B1 (de)
EP (1) EP1071397B1 (de)
JP (2) JP4566402B2 (de)
KR (1) KR100960597B1 (de)
CN (1) CN1248691C (de)
AR (1) AR019096A1 (de)
AT (1) ATE258425T1 (de)
AU (1) AU756641B2 (de)
BG (1) BG64839B1 (de)
BR (1) BR9909869A (de)
CA (1) CA2329234C (de)
CO (1) CO5070607A1 (de)
CZ (1) CZ295194B6 (de)
DE (1) DE69914472T2 (de)
DK (1) DK1071397T3 (de)
EA (1) EA002829B1 (de)
EE (1) EE04220B1 (de)
ES (1) ES2215379T3 (de)
FI (1) FI980901A (de)
GE (1) GEP20032906B (de)
HK (1) HK1034032A1 (de)
HR (1) HRP20000704B1 (de)
HU (1) HUP0101458A3 (de)
ID (1) ID27987A (de)
IL (2) IL138951A0 (de)
MX (1) MXPA00010367A (de)
NO (1) NO329809B1 (de)
NZ (1) NZ507453A (de)
PL (1) PL197447B1 (de)
PT (1) PT1071397E (de)
RS (1) RS49962B (de)
SI (1) SI1071397T1 (de)
SK (1) SK285427B6 (de)
TR (1) TR200003102T2 (de)
TW (1) TWI224507B (de)
UA (1) UA68376C2 (de)
WO (1) WO1999055305A2 (de)
ZA (1) ZA200005632B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
US20040224017A1 (en) * 2003-03-14 2004-11-11 Nirmal Mulye Process for preparing sustained release tablets
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
CN107029220A (zh) 2008-06-30 2017-08-11 托卡根公司 5‑氟胞嘧啶制剂及其用途
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555304B2 (en) 1982-04-05 1986-09-18 Merck Sharp & Dohme Limited Stabilization of drugs in alginic acid and magnesium hydroxide granules
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia

Also Published As

Publication number Publication date
MXPA00010367A (es) 2002-06-04
EA200001098A1 (ru) 2001-04-23
BG104959A (en) 2001-07-31
ZA200005632B (en) 2002-01-14
ATE258425T1 (de) 2004-02-15
KR100960597B1 (ko) 2010-06-07
UA68376C2 (en) 2004-08-16
CN1248691C (zh) 2006-04-05
HUP0101458A3 (en) 2002-05-28
NO20005313D0 (no) 2000-10-20
CO5070607A1 (es) 2001-08-28
CN1301163A (zh) 2001-06-27
TWI224507B (en) 2004-12-01
US7045147B1 (en) 2006-05-16
EA002829B1 (ru) 2002-10-31
SK285427B6 (sk) 2007-01-04
KR20010071172A (ko) 2001-07-28
JP2010083900A (ja) 2010-04-15
RS49962B (sr) 2008-09-29
NO20005313L (no) 2000-11-21
SK15542000A3 (sk) 2001-08-06
DK1071397T3 (da) 2004-04-05
WO1999055305A2 (en) 1999-11-04
EE200000617A (et) 2002-06-17
CA2329234A1 (en) 1999-11-04
HRP20000704A2 (en) 2001-04-30
WO1999055305A3 (en) 1999-12-29
IL138951A0 (en) 2001-11-25
ID27987A (id) 2001-05-03
SI1071397T1 (en) 2004-06-30
CA2329234C (en) 2008-06-10
TR200003102T2 (tr) 2001-02-21
EP1071397B1 (de) 2004-01-28
CZ20003780A3 (en) 2001-05-16
EE04220B1 (et) 2004-02-16
FI980901A (fi) 1999-10-24
AU756641B2 (en) 2003-01-16
BR9909869A (pt) 2000-12-19
DE69914472T2 (de) 2004-11-11
AU3524699A (en) 1999-11-16
HK1034032A1 (en) 2001-10-12
PT1071397E (pt) 2004-06-30
PL197447B1 (pl) 2008-03-31
NZ507453A (en) 2003-02-28
JP2002512946A (ja) 2002-05-08
IL138951A (en) 2006-10-31
GEP20032906B (en) 2003-02-25
CZ295194B6 (cs) 2005-06-15
BG64839B1 (bg) 2006-06-30
EP1071397A2 (de) 2001-01-31
HRP20000704B1 (en) 2009-11-30
JP4566402B2 (ja) 2010-10-20
NO329809B1 (no) 2010-12-20
PL344078A1 (en) 2001-09-24
ES2215379T3 (es) 2004-10-01
YU63900A (sh) 2003-07-07
AR019096A1 (es) 2001-12-26
FI980901A0 (fi) 1998-04-23
HUP0101458A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
DE69723303D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
DE69922964D1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DE69427472T2 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
ATE209497T1 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
DE69813602T2 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
NO992944D0 (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
EE04955B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
DE60037897D1 (de) Orales arzneimittel mit verzögerter wirkstoffabgabe
DE69713505T2 (de) Arzneimittel enthaltend mizolastin mit verzögerter wirkstoffabgabe
ATE256465T1 (de) Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
DE69622648D1 (de) Benzoxalepin-derivate, deren salze und diese enthaltende arzneimittel
NO971574D0 (no) Medisinmateanordning for tildeling av medisin via munnen særlig beregnet for mindre barn
NO20003284L (no) Farmasøytisk preparat for oral administrering
DE69724435D1 (de) Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition